Latest Announcements

BSE & NSE corporate filings with AI summaries

BSEBoard MeetingResults4 Nov 2026

Rajeswari Infrastructure Ltd

Pursuant to Regulation 30 & 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that, based on the recommendation and approval of the Board of Directors in its meeting held on 04thNovember, 2026 has, inter alia considered and approved the following: 1.Unaudited Financial Results of the Company for the quarter ended September 30, 2026. A copy of the Unaudited Standalone Financial Results ....

Rajeswari Infrastructure Ltd has announced its unaudited financial results for the quarter ended September 30, 2026, which were reviewed by the Audit Committee and approved by the Board of Directors. The company has also disclosed that it was admitted into the Corporate Insolvency Resolution Process (CIRP) under the Insolvency and Bankruptcy Code, 2016.

Read more →📎 1 attachment
BSECompany UpdateRegulatory4 Nov 2026

Samtex Fashions Ltd-$

Intimation regarding Demand Notice dated 30.10.2026, Recovery Certificate dated 23.10.2026 issued in the case no. TA/446/2022 in the matter of NARCL Vs. SSA International Ltd. & Ors.

Samtex Fashions Ltd has received a Demand Notice and Recovery Certificate from DRT-III in a case related to NARCL vs. SSA International Ltd. The company has been held jointly and severally liable for ₹437,57,28,362.70, along with interest and costs. The company is evaluating the financial impact and legal remedies.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults4 Nov 2026

TVS Motor Company Ltd

Compliance under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015

TVS Motor Company Ltd has announced its Q2 FY27 earnings, with the company achieving its highest ever sales volume, revenue, and profits. The sales volume grew 27% to 1.9 million units, revenue grew 44% to INR17,103 crores, and EBITDA grew 47% to INR2,219 crores. The company has also approved a scheme of demerger of its consumer finance and related business undertaking from the company.

Read more →📎 1 attachment
BSECompany UpdateMgmt Change4 Nov 2026

Dr. Lal Path Labs Ltd.

Dr. Lal Path Labs Ltd. has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left">&nbsp;</td><td class="TTRow_left"><b>&nbsp;Details</b></td></tr> <tr><td ....

Dr. Lal Path Labs Ltd. has informed BSE about the appointment of a Non-Executive Independent Director.

BSECompany UpdateMgmt Change4 Nov 2026

Dr. Lal Path Labs Ltd.

Dr. Lal Path Labs Ltd. has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left">&nbsp;</td><td class="TTRow_left"><b>&nbsp;Details</b></td></tr> <tr><td ....

Dr. Lal Path Labs Ltd. has informed BSE about the appointment of a Non-Executive Independent Director.

BSECompany UpdateMgmt Change4 Nov 2026

Dr. Lal Path Labs Ltd.

Dr. Lal Path Labs Ltd. has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left">&nbsp;</td><td class="TTRow_left"><b>&nbsp;Details</b></td></tr> <tr><td ....

Dr. Lal Path Labs Ltd. has informed BSE about the appointment of a Non-Executive Independent Director.

BSECompany UpdateMgmt Change4 Nov 2026

Dr. Lal Path Labs Ltd.

Dr. Lal Path Labs Ltd. has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left">&nbsp;</td><td class="TTRow_left"><b>&nbsp;Details</b></td></tr> <tr><td ....

Dr. Lal Path Labs Ltd. has informed BSE about the appointment of a Non-Executive Independent Director.

BSECompany UpdateMgmt Change4 Nov 2026

Dr. Lal Path Labs Ltd.

Dr. Lal Path Labs Ltd. has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left">&nbsp;</td><td class="TTRow_left"><b>&nbsp;Details</b></td></tr> <tr><td ....

Dr. Lal Path Labs Ltd. has informed BSE about the appointment of a Non-Executive Independent Director.

BSECompany UpdateMgmt Change4 Nov 2026

Dr. Lal Path Labs Ltd.

Dr. Lal Path Labs Ltd. has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left">&nbsp;</td><td class="TTRow_left"><b>&nbsp;Details</b></td></tr> <tr><td ....

Dr. Lal Path Labs Ltd. has informed BSE about the appointment of a Non-Executive Independent Director.

BSECompany UpdateMgmt Change4 Nov 2026

Dr. Lal Path Labs Ltd.

Dr. Lal Path Labs Ltd. has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left">&nbsp;</td><td class="TTRow_left"><b>&nbsp;Details</b></td></tr> <tr><td ....

Dr. Lal Path Labs Ltd. has informed BSE about the appointment of a Non-Executive Independent Director.

BSECompany UpdateMgmt Change4 Nov 2026

Dr. Lal Path Labs Ltd.

Dr. Lal Path Labs Ltd. has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left">&nbsp;</td><td class="TTRow_left"><b>&nbsp;Details</b></td></tr> <tr><td ....

Dr. Lal Path Labs Ltd. has informed BSE about the appointment of a Non-Executive Independent Director.

BSECompany UpdateMgmt Change4 Nov 2026

Dr. Lal Path Labs Ltd.

Dr. Lal Path Labs Ltd. has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left">&nbsp;</td><td class="TTRow_left"><b>&nbsp;Details</b></td></tr> <tr><td ....

Dr. Lal Path Labs Ltd. has informed BSE about the appointment of a Non-Executive Independent Director.

BSECompany UpdateMgmt Change4 Nov 2026

Dr. Lal Path Labs Ltd.

Dr. Lal Path Labs Ltd. has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left">&nbsp;</td><td class="TTRow_left"><b>&nbsp;Details</b></td></tr> <tr><td ....

Dr. Lal Path Labs Ltd. has appointed a Non-Executive Independent Director.

BSECompany UpdateMgmt Change4 Nov 2026

Dr. Lal Path Labs Ltd.

Dr. Lal Path Labs Ltd. has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left">&nbsp;</td><td class="TTRow_left"><b>&nbsp;Details</b></td></tr> <tr><td ....

Dr. Lal Path Labs Ltd. has informed BSE about the appointment of a Non-Executive Independent Director.

BSECompany UpdateMgmt Change4 Nov 2026

Dr. Lal Path Labs Ltd.

Dr. Lal Path Labs Ltd. has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left">&nbsp;</td><td class="TTRow_left"><b>&nbsp;Details</b></td></tr> <tr><td ....

Dr. Lal Path Labs Ltd. has informed BSE about the appointment of a Non-Executive Independent Director.

BSECompany UpdateMgmt Change4 Nov 2026

Dr. Lal Path Labs Ltd.

Dr. Lal Path Labs Ltd. has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left">&nbsp;</td><td class="TTRow_left"><b>&nbsp;Details</b></td></tr> <tr><td ....

Dr. Lal Path Labs Ltd. has informed BSE about the appointment of a Non-Executive Independent Director.

BSECompany UpdateMgmt Change4 Nov 2026

Dr. Lal Path Labs Ltd.

Dr. Lal Path Labs Ltd. has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left">&nbsp;</td><td class="TTRow_left"><b>&nbsp;Details</b></td></tr> <tr><td ....

Dr. Lal Path Labs Ltd. has informed BSE about the appointment of a Non-Executive Independent Director.

BSECompany UpdateMgmt Change4 Nov 2026

Dr. Lal Path Labs Ltd.

Dr. Lal Path Labs Ltd. has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left">&nbsp;</td><td class="TTRow_left"><b>&nbsp;Details</b></td></tr> <tr><td ....

Dr. Lal Path Labs Ltd. has informed BSE about the appointment of a Non-Executive Independent Director.

← PreviousPage 1748 of 12024Next →